<http://webisa.webdatacommons.org/prov/512026523>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/4151358> .
<http://webisa.webdatacommons.org/4151358>	<http://www.w3.org/ns/prov#value>	"Patients with such complications as Parkinson's disease, schizophrenia, dementia, renal failure, or other severe complication, and patients who have the anamnesis of hypersensitivity to edaravone." .
<http://webisa.webdatacommons.org/4151358>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<clinicaltrials.gov> .
<http://webisa.webdatacommons.org/4151358>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .